QPER Health

Cover Block

PUBLIC

Name	QPER Health
Tagline	A digital health startup offering a personal health management app and connected device for quantitatively personalized solutions.
Headquarters	Boston, United States
Founded	2019
Stage	Pre-Seed
Business Model	Direct-to-Consumer (DTC)
Industry	Healthtech
Technology
Geography	North America
Growth Profile	Venture Scale
Founding Team	Solo Founder
Funding Label
Total Disclosed

Links

PUBLIC

• Website: https://qper.health/
• LinkedIn: https://www.linkedin.com/company/doxhealth

Executive Summary

PUBLIC

QPER Health is a pre-launch digital health startup attempting to build a direct-to-consumer subscription business around a quantified, device-driven approach to personal health management, a bet that merits investor attention for its focus on a data-centric wedge into a crowded market. The company, operated by Dox Health, Inc., was founded in 2019 by Rajiv P. Shrestha, a PhD researcher with a background in pharmacy and health services, and has operated quietly since, with no public disclosure of institutional funding [Tracxn, 2026] [ResearchGate, retrieved 2026]. Its core product is a combined app and connected device ecosystem, requiring users to purchase a blood glucose monitor, blood pressure monitor, and scale, which feeds data into a platform designed to model cardiometabolic health over 26-week cycles [QPER Health App Store, retrieved 2026] [DOX Health, Inc., retrieved 2026]. Differentiation is claimed through a "quantitatively personalized" methodology and a patented Health Map, though the technology remains unproven outside of company materials [QPER Health, 2024]. The business model is purely DTC, relying on a pre-registration waitlist with a refundable $1 fee that converts to a subscription and one-time device charge at launch, indicating a go-to-market strategy built on organic user acquisition [QPER Health, 2024-2025]. Over the next 12-18 months, the critical watchpoints are the commercial launch and initial user retention metrics, validation of the clinical utility of its health model, and any shift toward enterprise or payer partnerships to expand beyond a self-pay consumer base.

Data Accuracy: YELLOW -- Core product and business model claims are confirmed by the company's own sites; founding date and team size are corroborated by one or two secondary sources (Tracxn, RocketReach). No independent validation of funding, technology, or market traction.

Taxonomy Snapshot

Axis	Value
Stage	Pre-Seed
Business Model	Direct-to-Consumer (DTC)
Industry / Vertical	Healthtech
Geography	North America
Growth Profile	Venture Scale
Founding Team	Solo Founder

Company Overview

PUBLIC

QPER Health operates as a digital health startup focused on personal health management, with its public presence tied to Dox Health, Inc., a small corporate entity based in Boston. The company was founded in 2019 by Rajiv P. Shrestha, a pharmaceutical health service researcher and pharmacist by background [Tracxn, 2026] [ResearchGate, retrieved 2026]. Public records describe Dox Health, Inc. as a company with four employees, operating in the 2-10 employee range typical of early-stage ventures [RocketReach, retrieved 2026] [Wellfound, retrieved 2024].

Key milestones are limited to product and brand development. The company introduced the QPER Health brand publicly in 2024 via a blog post announcing its mission to transform personal health management [QPER Health Blog, 2024]. That same year, the company launched a pre-registration website where consumers can sign up for early access to the forthcoming QPER Health app and device by paying a refundable $1 fee [QPER Health main site, 2024-2025]. This marks the primary public-facing milestone to date, signaling a pre-launch, direct-to-consumer acquisition strategy.

Data Accuracy: YELLOW -- Founding year and founder background are corroborated by one source each; team size and entity details are reported by employment data platforms but lack independent verification from major business registries.

Product and Technology

MIXED The product is a direct-to-consumer health management system, currently in a pre-launch phase that centers on a waitlist and a connected device bundle. According to the company's website, the user journey begins with a pre-registration that includes a refundable $1.00 fee [QPER Health, 2024-2025]. Upon launch, users are charged a first subscription fee and a one-time device fee before gaining access to the QPER Health app [QPER Health, 2024-2025]. This model positions the offering as a paid, hardware-enabled subscription service from day one, targeting individuals willing to commit to an unproven platform.

The core technology, as described by the operating entity Dox Health, Inc., is built around a clear input-output model of health, tracking how key cardiometabolic outputs respond over time [DOX Health, Inc. main site, retrieved 2026]. The platform incorporates a patented Health Map and includes tracking for steps, sleep, movement, and nutrition [DOX Health, Inc. main site, retrieved 2026]. The required connected devices,a blood glucose monitor, a blood pressure monitor, and a weighing scale,are listed for sale on the company's website, indicating a closed ecosystem where the hardware is a prerequisite for the software service [QPER Health App Store, retrieved 2026]. The company's public language emphasizes "quantitatively personalized solutions," suggesting an ambition to move beyond generic health tracking to data-driven, individualized insights [QPER Health, 2024].

Data Accuracy: YELLOW -- Product details are sourced from the company's own websites and app store listing; no independent reviews or user testimonials are available.

Market Research

PUBLIC The market for consumer-driven health technology is expanding, driven by a confluence of rising healthcare costs, greater personal data ownership, and a post-pandemic focus on preventative care. For QPER Health, which positions itself at the intersection of connected devices, data aggregation, and personalized insights, the relevant market is a subset of the broader digital health and wellness monitoring landscape.

Quantifying the precise addressable market for a pre-launch, direct-to-consumer health platform is challenging without company disclosures. Third-party market research on the specific category of "quantitatively personalized health management" is not available. However, analogous market sizing for connected health and wellness devices provides a directional view. The global market for wearable health monitoring devices, a core component of QPER's proposed solution, was valued at approximately $20 billion in 2023 and is projected to grow at a compound annual rate above 15% through the decade [Grand View Research, 2024]. This growth is underpinned by several demand drivers: an aging global population managing chronic conditions, increased consumer comfort with health-tracking technology, and a shift in payer and employer models toward value-based care that incentivizes prevention.

Key adjacent and substitute markets include the broader digital therapeutics and chronic condition management software segments, which often follow a B2B2C model through employers or insurers. QPER's initial DTC approach targets a different, and potentially more fragmented, customer base: health-conscious individuals willing to pay out-of-pocket for advanced insights. A significant macro force is the evolving regulatory landscape for digital health products, particularly in the United States. While QPER's current materials do not mention FDA clearance or other regulatory pathways, any platform that integrates data from medical-grade devices (like blood glucose and pressure monitors) to generate health recommendations operates in a space increasingly scrutinized for clinical validity and data privacy.

Metric	Value
Wearable Health Devices (Global) 2023	20 $B
Projected CAGR 2024-2030	15 %

The projected growth in the underlying device category suggests a receptive environment for new entrants, but it does not guarantee demand for a specific, integrated software layer. The market opportunity hinges on QPER's ability to demonstrate unique value beyond the raw data provided by standalone devices from established manufacturers.

Data Accuracy: YELLOW -- Market sizing is based on an analogous, publicly reported segment; specific TAM for QPER's niche is not confirmed.

Competitive Landscape

MIXED QPER Health enters a crowded market for digital health tools with a pre-launch, direct-to-consumer offering centered on a connected device and a quantitative health map, a positioning that places it against established wellness apps and a growing field of specialized health monitoring startups.

The competitive analysis proceeds based on the general market context and the company's stated positioning.

Mapping the competitive field requires segmenting by both business model and product focus. QPER Health's direct-to-consumer subscription and device fee model places it in the crowded consumer wellness app segment, competing for user attention and wallet share against mass-market platforms like Fitbit and Apple Health. These incumbents benefit from massive installed hardware bases and integrated operating systems, creating a high barrier for any new standalone device. Adjacent to these are specialized digital therapeutics and chronic condition management platforms, such as Omada Health for diabetes or Livongo (now part of Teladoc), which often operate through employer or payer contracts rather than direct consumer sales. QPER Health's emphasis on quantitative, cardiometabolic tracking suggests it may be targeting the latter's user needs but through a DTC wedge, avoiding the lengthy sales cycles of the B2B2C model.

Where QPER Health claims a defensible edge today is in its specific framing of "quantitatively personalized" health via a proprietary Health Map, a concept detailed on the DOX Health site [DOX Health, Inc. main site, retrieved 2026]. This intellectual property, coupled with a requirement for specific medical devices (glucose monitor, blood pressure monitor, scale) [QPER Health App Store, retrieved 2026], suggests an attempt to build a more clinically rigorous data foundation than general wellness apps. However, this edge is perishable. It depends entirely on successful product launch and user adoption to generate the proprietary longitudinal data required to validate and improve the Health Map algorithm. Without a launched product or user base, the claimed differentiation remains a theoretical advantage.

The company's most significant exposure lies in its limited channels and capital position. It lacks the distribution muscle of app store giants, the sales infrastructure to reach employers or health systems, and any evidence of institutional funding to subsidize customer acquisition or device costs. A competitor like Whoop, with its strong brand and community-driven marketing, or a gluco-monitoring specialist like Levels, which has cultivated a dedicated biohacker following, could easily extend their own platforms into broader cardiometabolic tracking, leveraging existing user trust and capital. QPER Health's pre-registration model [QPER Health main site, 2024-2025] is a common customer acquisition tactic but offers no durable channel ownership.

The most plausible 18-month scenario hinges on launch execution. If QPER Health successfully ships its integrated device and app, attracts a niche community of data-obsessed early adopters, and demonstrates improved user health outcomes, it could carve out a sustainable position as a specialist in quantitative self-care. The "winner" in this case would be a company like Levels, which has already validated demand for metabolic health tracking; QPER Health would need to match that community engagement. Conversely, if the launch falters or user retention is low, QPER Health becomes a "loser" in the face of platform expansion. Apple, with its deepening health ecosystem and research initiatives, could introduce similar composite health scoring, leveraging its hardware ubiquity to render standalone solutions like QPER's redundant.

Data Accuracy: YELLOW -- Competitive context is inferred from market observation; specific competitor claims and comparisons are not sourced from direct company disclosures.

Opportunity

PUBLIC The prize for QPER Health is a direct-to-consumer health management platform that captures recurring revenue from a large, engaged user base by becoming a trusted, data-driven partner for lifelong health decisions.

The headline opportunity is the creation of a category-defining, quantitatively personalized health operating system for individuals. This outcome is reachable because the company has already defined a clear, patent-backed technical framework and a direct-to-consumer go-to-market motion that bypasses traditional healthcare gatekeepers. The platform's core proposition, as described on its own site, is to help users "take control of their lifelong health journey, 26 weeks at a time" by bridging gaps in healthcare accessibility and efficiency [QPER Health, About us]. The evidence that makes this more than an aspiration is the existence of a functional pre-registration system, a defined product architecture with a connected device ecosystem, and a founder with a research background in health services, suggesting a methodical rather than purely marketing-driven approach [QPER Health main site, 2024-2025] [ResearchGate, retrieved 2026].

Growth would likely follow one of several concrete paths, each requiring a distinct catalyst. The scenarios below outline plausible routes to scale.

Scenario	What happens	Catalyst	Why it's plausible
DTC Subscription Scale	The app and device bundle achieves viral adoption among health-conscious consumers, converting pre-registrants into long-term subscribers.	A successful public launch and positive user reviews drive organic word-of-mouth and app store visibility.	The pre-registration model and refundable fee indicate an existing waitlist-building strategy focused on individual buyers, a proven DTC health tech wedge [QPER Health main site, 2024-2025].
Vertical Integration into Chronic Care	The platform evolves from general wellness into a clinically integrated tool for managing specific conditions like prediabetes or hypertension.	Partnerships with telehealth providers or digital pharmacy services to offer QPER as a bundled monitoring solution.	The required device list (blood glucose monitor, blood pressure monitor) aligns directly with chronic condition management, suggesting a natural product roadmap [QPER Health App Store, retrieved 2026].
B2B2C Employer Pivot	QPER Health is adopted as a corporate wellness benefit, with employers subsidizing subscriptions for employees.	A pilot deal with a mid-sized employer or a partnership with a benefits administrator.	The focus on quantifiable cardiometabolic outputs creates a value proposition around reducing healthcare costs and improving productivity, which resonates with employer buyers [DOX Health, Inc. main site, retrieved 2026].

Compounding for QPER Health would manifest as a data network effect. Each additional user contributes more longitudinal health data, which the company states is analyzed through its "clear input-output model of health" [DOX Health, Inc. main site, retrieved 2026]. A larger, more diverse dataset would improve the platform's personalization algorithms, making recommendations more accurate and sticky for existing users while also serving as a barrier to entry for competitors. The flywheel begins to spin if early adopters achieve measurable health improvements, share their results, and drive referral loops within their communities. There is no public evidence yet of this effect in motion, as the platform is pre-launch.

The size of the win can be contextualized by looking at comparable DTC health platforms that have reached significant scale. For example, Noom, a behavior change platform for weight and chronic condition management, was valued at approximately $3.7 billion during its funding rounds in 2021 [Forbes, 2021]. If the DTC Subscription Scale scenario plays out and QPER Health captures a meaningful segment of the personalized health management market, it could aim for a valuation in the hundreds of millions to low billions of dollars, depending on user growth and retention metrics. This is a scenario-based comparable, not a forecast.

Data Accuracy: YELLOW -- Opportunity analysis is based on company claims and product descriptions; growth scenarios are plausible extrapolations but lack external validation of execution.

Sources

PUBLIC

1. [Tracxn, 2026] QPER Health - 2026 Company Profile, Team, Funding & Competitors | https://tracxn.com/d/companies/qperhealth/__rkvBJmIbRnOTlpItk7GcN3smoHykwOCT0OgxDF4tZqM

2. [ResearchGate, retrieved 2026] Rajeev SHRESTHA | PhD Candidate | Bachelor of Pharmacy | Newcastle University, Newcastle upon Tyne | NCL | Research profile | https://www.researchgate.net/profile/Rajeev-Shrestha-2

3. [QPER Health App Store, retrieved 2026] QPER Health App Store listing | https://apps.apple.com/us/app/qper-health/id6738475658

4. [DOX Health, Inc. main site, retrieved 2026] DOX Health, Inc. | https://doxhx.com/

5. [QPER Health, 2024] Introducing QPER Health: Revolutionizing Personal Health Management | https://blog.qper.health/introducing-qper-health/

6. [QPER Health main site, 2024-2025] QPER Health | https://qper.health/

7. [QPER Health, About us] About us - QPER Health | https://qper.health/about-us

8. [RocketReach, retrieved 2026] DOX Health, Inc. Information | https://rocketreach.co/dox-health-inc-management_b78fadf4c255d5c6

9. [Wellfound, retrieved 2024] DOX Health, Inc. profile | https://wellfound.com/company/dox-health-inc

10. [Grand View Research, 2024] Wearable Health Monitoring Devices Market Size, Share & Trends Analysis Report | https://www.grandviewresearch.com/industry-analysis/wearable-health-monitoring-devices-market

11. [Forbes, 2021] Noom Valued At $3.7 Billion After Latest Funding Round | https://www.forbes.com/sites/alexkonrad/2021/05/26/noom-valued-at-37-billion-after-latest-funding-round/